loading
Tectonic Therapeutic Inc stock is traded at $16.80, with a volume of 683.46K. It is down -2.72% in the last 24 hours and down -25.43% over the past month. Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.
See More
Previous Close:
$17.27
Open:
$17.3
24h Volume:
683.46K
Relative Volume:
2.39
Market Cap:
$314.36M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-34.22%
1M Performance:
-25.43%
6M Performance:
-29.88%
1Y Performance:
-8.05%
1-Day Range:
Value
$16.72
$18.03
1-Week Range:
Value
$15.34
$19.75
52-Week Range:
Value
$13.70
$61.07

Tectonic Therapeutic Inc Stock (TECX) Company Profile

Name
Name
Tectonic Therapeutic Inc
Name
Phone
(339) 666-3320
Name
Address
490 ARSENAL WAY, WATERTOWN
Name
Employee
51
Name
Twitter
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
TECX's Discussions on Twitter

Compare TECX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
TECX
Tectonic Therapeutic Inc
16.80 323.16M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
396.12 101.77B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
573.38 60.12B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
452.00 59.45B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
750.78 44.90B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
341.80 35.07B 3.81B -644.79M -669.77M -6.24

Tectonic Therapeutic Inc Stock (TECX) Upgrades & Downgrades

Date Action Analyst Rating Change
Sep-03-25 Initiated Oppenheimer Outperform
Jul-21-25 Initiated Truist Buy
Jun-11-25 Resumed Raymond James Outperform
Apr-21-25 Initiated Mizuho Outperform
Nov-20-24 Initiated Raymond James Outperform
Aug-22-24 Initiated Wells Fargo Overweight
Jun-26-24 Initiated Piper Sandler Overweight
Jun-24-24 Initiated TD Cowen Buy
Dec-18-23 Downgrade Mizuho Buy → Neutral
Jan-05-22 Downgrade BTIG Research Buy → Neutral
Nov-19-21 Downgrade Morgan Stanley Overweight → Equal-Weight
Jun-15-21 Initiated BTIG Research Buy
May-27-21 Initiated Needham Buy
Mar-09-21 Initiated Barclays Overweight
Mar-02-21 Initiated Stifel Hold
Nov-11-20 Initiated Berenberg Buy
Mar-31-20 Downgrade H.C. Wainwright Buy → Neutral
Jun-27-19 Initiated Mizuho Buy
Apr-05-19 Initiated Janney Buy
Oct-10-18 Initiated Guggenheim Buy
Oct-02-18 Reiterated H.C. Wainwright Buy
Sep-17-18 Initiated H.C. Wainwright Buy
Jul-16-18 Initiated Wedbush Outperform
Jul-16-18 Initiated Wells Fargo Outperform
View All

Tectonic Therapeutic Inc Stock (TECX) Latest News

pulisher
03:22 AM

Should you hold or exit Tectonic Therapeutic Inc. nowMarket Growth Report & Comprehensive Market Scan Reports - Newser

03:22 AM
pulisher
01:29 AM

Why Tectonic Therapeutic Inc. is moving todayMarket Performance Report & High Accuracy Investment Signals - Newser

01:29 AM
pulisher
Sep 06, 2025

Can Tectonic Therapeutic Inc. recover in the next quarterBear Alert & Low Drawdown Momentum Trade Ideas - Newser

Sep 06, 2025
pulisher
Sep 06, 2025

Tectonic Therapeutic Inc.’s volatility index tracking explained2025 Volume Leaders & Low Risk High Win Rate Stock Picks - Newser

Sep 06, 2025
pulisher
Sep 06, 2025

Using Python tools to backtest Tectonic Therapeutic Inc. strategiesTrade Analysis Report & Verified Swing Trading Watchlists - Newser

Sep 06, 2025
pulisher
Sep 05, 2025

Can Tectonic Therapeutic Inc. stock outperform in a bear marketEarnings Trend Report & Low Risk High Reward Ideas - خودرو بانک

Sep 05, 2025
pulisher
Sep 05, 2025

Institutional scanner results for Tectonic Therapeutic Inc.July 2025 Action & Weekly Setup with High ROI Potential - Newser

Sep 05, 2025
pulisher
Sep 04, 2025

Tectonic pullback on Eli Lilly relaxin data ‘overdone,’ says Truist - MSN

Sep 04, 2025
pulisher
Sep 04, 2025

Technical signs of recovery in Tectonic Therapeutic Inc.Portfolio Value Summary & Long-Term Growth Plans - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Top chart patterns to watch in Tectonic Therapeutic Inc.July 2025 Patterns & AI Forecast Swing Trade Picks - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Oppenheimer Holdings Inc. shares rise 2.11% premarket after initiating coverage on KB Home and Tectonic Therapeutic. - AInvest

Sep 04, 2025
pulisher
Sep 04, 2025

Does Tectonic Therapeutic Inc. show high probability of reboundInsider Selling & Short-Term Swing Trade Alerts - Newser

Sep 04, 2025
pulisher
Sep 03, 2025

Historical volatility pattern of Tectonic Therapeutic Inc. visualizedSell Signal & Expert Approved Trade Ideas - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Can Tectonic Therapeutic Inc. stock double in the next yearMarket Performance Summary & Weekly Stock Breakout Alerts - خودرو بانک

Sep 03, 2025
pulisher
Sep 03, 2025

Tectonic Therapeutic Initiates Coverage with Outperform Rating at Oppenheimer, Sets Price Target at $80 - AInvest

Sep 03, 2025
pulisher
Sep 03, 2025

Tectonic Therapeutic a new outperform at Oppenheimer on heart drug asset - Seeking Alpha

Sep 03, 2025
pulisher
Sep 03, 2025

Insiders Re-Evaluate Their US$62.6m Stock Purchase As Tectonic Therapeutic Falls To US$478m - 富途牛牛

Sep 03, 2025
pulisher
Sep 03, 2025

Tectonic Stock Soars Pre-market After Tuesday’s Sell-Off: Oppenheimer Is Hopeful About Company’s Lead Candidate - Asianet Newsable

Sep 03, 2025
pulisher
Sep 03, 2025

How to build a dashboard for Tectonic Therapeutic Inc. stockQuarterly Portfolio Review & AI Driven Price Predictions - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Oppenheimer initiates Tectonic Therapeutics stock with Outperform rating - Investing.com

Sep 03, 2025
pulisher
Sep 03, 2025

Tectonic Therapeutic shares rise 2.28% premarket after Oppenheimer initiates coverage with an Outperform rating. - AInvest

Sep 03, 2025
pulisher
Sep 03, 2025

Tectonic Therapeutic initiated with an Outperform at Oppenheimer - TipRanks

Sep 03, 2025
pulisher
Sep 03, 2025

Oppenheimer Initiates Tectonic Therapeutic at Outperform With $80 Price Target - MarketScreener

Sep 03, 2025
pulisher
Sep 03, 2025

Insider Purchases Worth US$62.6m See Losses As Tectonic Therapeutic Market Value Drops To US$478m - simplywall.st

Sep 03, 2025
pulisher
Sep 03, 2025

Detecting price anomalies in Tectonic Therapeutic Inc. with AIEarnings Recap Report & AI Driven Stock Price Forecasts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Visualizing Tectonic Therapeutic Inc. stock with heatmaps2025 Institutional Moves & Weekly Watchlist for Hot Stocks - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Visual analytics tools that track Tectonic Therapeutic Inc. performanceMarket Activity Recap & Precise Entry and Exit Recommendations - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Will Tectonic Therapeutic Inc. bounce back from current support2025 Trading Recap & Fast Exit and Entry Strategy Plans - Newser

Sep 03, 2025
pulisher
Sep 02, 2025

Confidence in Tectonic Therapeutic’s Strategic Approach Amid Eli Lilly’s Trial Setback - TipRanks

Sep 02, 2025
pulisher
Sep 02, 2025

Custom strategy builders for tracking Tectonic Therapeutic Inc.Market Performance Recap & Consistent Profit Alerts - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Tectonic Therapeutic shares fall 31.75% intraday after reporting Q2 2025 earnings and industry-wide layoffs. - AInvest

Sep 02, 2025
pulisher
Sep 02, 2025

Will Tectonic Therapeutic Inc. benefit from rate cutsTrade Analysis Report & Consistent Profit Trading Strategies - خودرو بانک

Sep 02, 2025
pulisher
Sep 02, 2025

Wellington Management Group LLP Invests $348,000 in Tectonic Therapeutic, Inc. $TECX - Defense World

Sep 02, 2025
pulisher
Sep 02, 2025

Short interest data insights for Tectonic Therapeutic Inc.Portfolio Return Summary & Risk Controlled Stock Pick Alerts - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Backtesting results for Tectonic Therapeutic Inc. trading strategies2025 Fundamental Recap & AI Driven Stock Price Forecasts - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Is now a turning point for Tectonic Therapeutic Inc.Earnings Summary Report & Accurate Entry/Exit Alerts - Newser

Sep 02, 2025
pulisher
Sep 01, 2025

Using data models to predict Tectonic Therapeutic Inc. stock movementMarket Weekly Review & Momentum Based Trading Ideas - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Can Tectonic Therapeutic Inc. be the next market leaderMarket Sentiment Review & Capital Efficient Trading Techniques - خودرو بانک

Sep 01, 2025
pulisher
Sep 01, 2025

What is the dividend yield of Tectonic Therapeutic Inc.Quarterly Earnings Report & Free Community Consensus Stock Picks - خودرو بانک

Sep 01, 2025

Tectonic Therapeutic Inc Stock (TECX) Financials Data

There is no financial data for Tectonic Therapeutic Inc (TECX). Check out other stocks for more information.

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Tectonic Therapeutic Inc Stock (TECX) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
SPRINGER TIMOTHY A
Director
Apr 10 '25
Buy
16.73
45,858
767,204
1,449,652
SPRINGER TIMOTHY A
Director
Apr 09 '25
Buy
14.76
21,071
311,020
1,403,794
SPRINGER TIMOTHY A
Director
Apr 11 '25
Buy
16.31
9,478
154,586
4,334,846
SPRINGER TIMOTHY A
Director
Apr 10 '25
Buy
16.73
8,092
135,379
4,325,368
SPRINGER TIMOTHY A
Director
Apr 09 '25
Buy
14.76
3,718
54,880
4,317,276
SPRINGER TIMOTHY A
Director
Apr 07 '25
Buy
17.10
412,500
7,053,750
1,382,723
SPRINGER TIMOTHY A
Director
Apr 07 '25
Buy
17.10
87,500
1,496,250
4,313,558
MCGUIRE TERRANCE
Director
Apr 07 '25
Sale
17.10
500,000
8,550,000
573,062
SPRINGER TIMOTHY A
Director
Feb 05 '25
Buy
50.00
660,000
33,000,000
970,223
SPRINGER TIMOTHY A
Director
Feb 05 '25
Buy
54.14
129,294
6,999,977
4,226,058
$86.64
price up icon 1.40%
$27.54
price up icon 0.58%
$25.98
price up icon 9.16%
$112.46
price up icon 8.66%
$145.10
price up icon 1.80%
biotechnology ONC
$341.80
price up icon 7.24%
Cap:     |  Volume (24h):